ARCHIVES OF DISEASE IN CHILDHOOD-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1087365, encodeId=db85108e365a7, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087366, encodeId=1268108e3667c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578533, encodeId=a32f5e8533ad, content=先查询下期刊文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571836, encodeId=11325e183622, content=三天秒拒，说创新性不够，有类似文章发表过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565818, encodeId=b67656581874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：这个杂志可能是BMJ的子刊，首先编辑审稿10天左右，然后外审2月，基本都是压着deadline，大修回去之后又审了1.5月，小修又是半个月，到正式online半年了，审稿严谨，而且太慢了。好文章不建议投这个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d892158901, createdName=jilei_lin_40832754, createdTime=Mon Jan 21 00:00:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832770, encodeId=dec6832e7038, content=adc本身是个临床性和社会性强的期刊，背后学会很强。儿科排名第13。审稿挺快的，如果不合适，会立刻告诉作者，不耽误改投。审稿人给的意见很中肯。 好像这个刊近年来在加强与中国的合作，投的人和中的人都不少。 其实这个刊和它的两本特刊fetal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Wed Jul 13 17:19:03 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517168, encodeId=fffa51e1682c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：欧洲儿科学会官刊，发表比较快，一审25天，接收2周后上线，审稿较严格，但只要写的认真就不算难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Fri Nov 27 14:41:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509696, encodeId=13f05096967b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：唉,我的文章投稿后被秒拒，死的原因都不知道，就说文章质量不行，唉，好郁闷，该杂志很多年前有过我这个文章的病的报道，之后就没有了，可能不对期刊口味，再一个，可能文章质量各方面都较差吧，还想有点审稿意见，可惜都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a59109196, createdName=zyzyyan, createdTime=Mon Feb 09 11:04:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505252, encodeId=abcc5052527a, content=该杂志很少发表病例报道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Aug 12 09:46:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492288, encodeId=74ed492288d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2021-12-27 学医的彭于晏

什么是协同作用？什么是相加作用？两者有什么区别？

124 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1087365, encodeId=db85108e365a7, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087366, encodeId=1268108e3667c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578533, encodeId=a32f5e8533ad, content=先查询下期刊文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571836, encodeId=11325e183622, content=三天秒拒，说创新性不够，有类似文章发表过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565818, encodeId=b67656581874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：这个杂志可能是BMJ的子刊，首先编辑审稿10天左右，然后外审2月，基本都是压着deadline，大修回去之后又审了1.5月，小修又是半个月，到正式online半年了，审稿严谨，而且太慢了。好文章不建议投这个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d892158901, createdName=jilei_lin_40832754, createdTime=Mon Jan 21 00:00:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832770, encodeId=dec6832e7038, content=adc本身是个临床性和社会性强的期刊，背后学会很强。儿科排名第13。审稿挺快的，如果不合适，会立刻告诉作者，不耽误改投。审稿人给的意见很中肯。 好像这个刊近年来在加强与中国的合作，投的人和中的人都不少。 其实这个刊和它的两本特刊fetal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Wed Jul 13 17:19:03 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517168, encodeId=fffa51e1682c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：欧洲儿科学会官刊，发表比较快，一审25天，接收2周后上线，审稿较严格，但只要写的认真就不算难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Fri Nov 27 14:41:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509696, encodeId=13f05096967b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：唉,我的文章投稿后被秒拒，死的原因都不知道，就说文章质量不行，唉，好郁闷，该杂志很多年前有过我这个文章的病的报道，之后就没有了，可能不对期刊口味，再一个，可能文章质量各方面都较差吧，还想有点审稿意见，可惜都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a59109196, createdName=zyzyyan, createdTime=Mon Feb 09 11:04:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505252, encodeId=abcc5052527a, content=该杂志很少发表病例报道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Aug 12 09:46:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492288, encodeId=74ed492288d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2021-12-27 桑晒麦拉

一般期刊要求几张图/几个表？

128 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1087365, encodeId=db85108e365a7, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087366, encodeId=1268108e3667c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578533, encodeId=a32f5e8533ad, content=先查询下期刊文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571836, encodeId=11325e183622, content=三天秒拒，说创新性不够，有类似文章发表过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565818, encodeId=b67656581874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：这个杂志可能是BMJ的子刊，首先编辑审稿10天左右，然后外审2月，基本都是压着deadline，大修回去之后又审了1.5月，小修又是半个月，到正式online半年了，审稿严谨，而且太慢了。好文章不建议投这个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d892158901, createdName=jilei_lin_40832754, createdTime=Mon Jan 21 00:00:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832770, encodeId=dec6832e7038, content=adc本身是个临床性和社会性强的期刊，背后学会很强。儿科排名第13。审稿挺快的，如果不合适，会立刻告诉作者，不耽误改投。审稿人给的意见很中肯。 好像这个刊近年来在加强与中国的合作，投的人和中的人都不少。 其实这个刊和它的两本特刊fetal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Wed Jul 13 17:19:03 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517168, encodeId=fffa51e1682c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：欧洲儿科学会官刊，发表比较快，一审25天，接收2周后上线，审稿较严格，但只要写的认真就不算难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Fri Nov 27 14:41:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509696, encodeId=13f05096967b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：唉,我的文章投稿后被秒拒，死的原因都不知道，就说文章质量不行，唉，好郁闷，该杂志很多年前有过我这个文章的病的报道，之后就没有了，可能不对期刊口味，再一个，可能文章质量各方面都较差吧，还想有点审稿意见，可惜都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a59109196, createdName=zyzyyan, createdTime=Mon Feb 09 11:04:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505252, encodeId=abcc5052527a, content=该杂志很少发表病例报道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Aug 12 09:46:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492288, encodeId=74ed492288d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

先查询下期刊文章类型

230 0

[GetPortalCommentsPageByObjectIdResponse(id=1087365, encodeId=db85108e365a7, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087366, encodeId=1268108e3667c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578533, encodeId=a32f5e8533ad, content=先查询下期刊文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571836, encodeId=11325e183622, content=三天秒拒，说创新性不够，有类似文章发表过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565818, encodeId=b67656581874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：这个杂志可能是BMJ的子刊，首先编辑审稿10天左右，然后外审2月，基本都是压着deadline，大修回去之后又审了1.5月，小修又是半个月，到正式online半年了，审稿严谨，而且太慢了。好文章不建议投这个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d892158901, createdName=jilei_lin_40832754, createdTime=Mon Jan 21 00:00:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832770, encodeId=dec6832e7038, content=adc本身是个临床性和社会性强的期刊，背后学会很强。儿科排名第13。审稿挺快的，如果不合适，会立刻告诉作者，不耽误改投。审稿人给的意见很中肯。 好像这个刊近年来在加强与中国的合作，投的人和中的人都不少。 其实这个刊和它的两本特刊fetal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Wed Jul 13 17:19:03 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517168, encodeId=fffa51e1682c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：欧洲儿科学会官刊，发表比较快，一审25天，接收2周后上线，审稿较严格，但只要写的认真就不算难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Fri Nov 27 14:41:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509696, encodeId=13f05096967b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：唉,我的文章投稿后被秒拒，死的原因都不知道，就说文章质量不行，唉，好郁闷，该杂志很多年前有过我这个文章的病的报道，之后就没有了，可能不对期刊口味，再一个，可能文章质量各方面都较差吧，还想有点审稿意见，可惜都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a59109196, createdName=zyzyyan, createdTime=Mon Feb 09 11:04:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505252, encodeId=abcc5052527a, content=该杂志很少发表病例报道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Aug 12 09:46:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492288, encodeId=74ed492288d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2019-06-03 a pediatrics surgeon

三天秒拒，说创新性不够，有类似文章发表过了。

275 0

[GetPortalCommentsPageByObjectIdResponse(id=1087365, encodeId=db85108e365a7, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087366, encodeId=1268108e3667c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578533, encodeId=a32f5e8533ad, content=先查询下期刊文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571836, encodeId=11325e183622, content=三天秒拒，说创新性不够，有类似文章发表过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565818, encodeId=b67656581874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：这个杂志可能是BMJ的子刊，首先编辑审稿10天左右，然后外审2月，基本都是压着deadline，大修回去之后又审了1.5月，小修又是半个月，到正式online半年了，审稿严谨，而且太慢了。好文章不建议投这个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d892158901, createdName=jilei_lin_40832754, createdTime=Mon Jan 21 00:00:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832770, encodeId=dec6832e7038, content=adc本身是个临床性和社会性强的期刊，背后学会很强。儿科排名第13。审稿挺快的，如果不合适，会立刻告诉作者，不耽误改投。审稿人给的意见很中肯。 好像这个刊近年来在加强与中国的合作，投的人和中的人都不少。 其实这个刊和它的两本特刊fetal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Wed Jul 13 17:19:03 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517168, encodeId=fffa51e1682c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：欧洲儿科学会官刊，发表比较快，一审25天，接收2周后上线，审稿较严格，但只要写的认真就不算难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Fri Nov 27 14:41:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509696, encodeId=13f05096967b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：唉,我的文章投稿后被秒拒，死的原因都不知道，就说文章质量不行，唉，好郁闷，该杂志很多年前有过我这个文章的病的报道，之后就没有了，可能不对期刊口味，再一个，可能文章质量各方面都较差吧，还想有点审稿意见，可惜都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a59109196, createdName=zyzyyan, createdTime=Mon Feb 09 11:04:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505252, encodeId=abcc5052527a, content=该杂志很少发表病例报道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Aug 12 09:46:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492288, encodeId=74ed492288d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2019-01-21 jilei_lin_40832754

审稿速度:3.0 | 投稿命中率:25.0
经验分享：这个杂志可能是BMJ的子刊，首先编辑审稿10天左右，然后外审2月，基本都是压着deadline，大修回去之后又审了1.5月，小修又是半个月，到正式online半年了，审稿严谨，而且太慢了。好文章不建议投这个。

296 0

[GetPortalCommentsPageByObjectIdResponse(id=1087365, encodeId=db85108e365a7, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087366, encodeId=1268108e3667c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578533, encodeId=a32f5e8533ad, content=先查询下期刊文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571836, encodeId=11325e183622, content=三天秒拒，说创新性不够，有类似文章发表过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565818, encodeId=b67656581874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：这个杂志可能是BMJ的子刊，首先编辑审稿10天左右，然后外审2月，基本都是压着deadline，大修回去之后又审了1.5月，小修又是半个月，到正式online半年了，审稿严谨，而且太慢了。好文章不建议投这个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d892158901, createdName=jilei_lin_40832754, createdTime=Mon Jan 21 00:00:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832770, encodeId=dec6832e7038, content=adc本身是个临床性和社会性强的期刊，背后学会很强。儿科排名第13。审稿挺快的，如果不合适，会立刻告诉作者，不耽误改投。审稿人给的意见很中肯。 好像这个刊近年来在加强与中国的合作，投的人和中的人都不少。 其实这个刊和它的两本特刊fetal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Wed Jul 13 17:19:03 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517168, encodeId=fffa51e1682c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：欧洲儿科学会官刊，发表比较快，一审25天，接收2周后上线，审稿较严格，但只要写的认真就不算难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Fri Nov 27 14:41:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509696, encodeId=13f05096967b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：唉,我的文章投稿后被秒拒，死的原因都不知道，就说文章质量不行，唉，好郁闷，该杂志很多年前有过我这个文章的病的报道，之后就没有了，可能不对期刊口味，再一个，可能文章质量各方面都较差吧，还想有点审稿意见，可惜都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a59109196, createdName=zyzyyan, createdTime=Mon Feb 09 11:04:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505252, encodeId=abcc5052527a, content=该杂志很少发表病例报道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Aug 12 09:46:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492288, encodeId=74ed492288d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2016-07-13 ms5469518383470847

adc本身是个临床性和社会性强的期刊，背后学会很强。儿科排名第13。审稿挺快的，如果不合适，会立刻告诉作者，不耽误改投。审稿人给的意见很中肯。
好像这个刊近年来在加强与中国的合作，投的人和中的人都不少。
其实这个刊和它的两本特刊fetal

190 0

[GetPortalCommentsPageByObjectIdResponse(id=1087365, encodeId=db85108e365a7, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087366, encodeId=1268108e3667c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578533, encodeId=a32f5e8533ad, content=先查询下期刊文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571836, encodeId=11325e183622, content=三天秒拒，说创新性不够，有类似文章发表过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565818, encodeId=b67656581874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：这个杂志可能是BMJ的子刊，首先编辑审稿10天左右，然后外审2月，基本都是压着deadline，大修回去之后又审了1.5月，小修又是半个月，到正式online半年了，审稿严谨，而且太慢了。好文章不建议投这个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d892158901, createdName=jilei_lin_40832754, createdTime=Mon Jan 21 00:00:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832770, encodeId=dec6832e7038, content=adc本身是个临床性和社会性强的期刊，背后学会很强。儿科排名第13。审稿挺快的，如果不合适，会立刻告诉作者，不耽误改投。审稿人给的意见很中肯。 好像这个刊近年来在加强与中国的合作，投的人和中的人都不少。 其实这个刊和它的两本特刊fetal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Wed Jul 13 17:19:03 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517168, encodeId=fffa51e1682c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：欧洲儿科学会官刊，发表比较快，一审25天，接收2周后上线，审稿较严格，但只要写的认真就不算难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Fri Nov 27 14:41:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509696, encodeId=13f05096967b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：唉,我的文章投稿后被秒拒，死的原因都不知道，就说文章质量不行，唉，好郁闷，该杂志很多年前有过我这个文章的病的报道，之后就没有了，可能不对期刊口味，再一个，可能文章质量各方面都较差吧，还想有点审稿意见，可惜都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a59109196, createdName=zyzyyan, createdTime=Mon Feb 09 11:04:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505252, encodeId=abcc5052527a, content=该杂志很少发表病例报道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Aug 12 09:46:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492288, encodeId=74ed492288d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2015-11-27 HawkingS2832

审稿速度:2.0 | 投稿命中率:25.0
经验分享：欧洲儿科学会官刊，发表比较快，一审25天，接收2周后上线，审稿较严格，但只要写的认真就不算难

487 0

[GetPortalCommentsPageByObjectIdResponse(id=1087365, encodeId=db85108e365a7, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087366, encodeId=1268108e3667c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578533, encodeId=a32f5e8533ad, content=先查询下期刊文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571836, encodeId=11325e183622, content=三天秒拒，说创新性不够，有类似文章发表过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565818, encodeId=b67656581874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：这个杂志可能是BMJ的子刊，首先编辑审稿10天左右，然后外审2月，基本都是压着deadline，大修回去之后又审了1.5月，小修又是半个月，到正式online半年了，审稿严谨，而且太慢了。好文章不建议投这个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d892158901, createdName=jilei_lin_40832754, createdTime=Mon Jan 21 00:00:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832770, encodeId=dec6832e7038, content=adc本身是个临床性和社会性强的期刊，背后学会很强。儿科排名第13。审稿挺快的，如果不合适，会立刻告诉作者，不耽误改投。审稿人给的意见很中肯。 好像这个刊近年来在加强与中国的合作，投的人和中的人都不少。 其实这个刊和它的两本特刊fetal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Wed Jul 13 17:19:03 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517168, encodeId=fffa51e1682c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：欧洲儿科学会官刊，发表比较快，一审25天，接收2周后上线，审稿较严格，但只要写的认真就不算难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Fri Nov 27 14:41:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509696, encodeId=13f05096967b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：唉,我的文章投稿后被秒拒，死的原因都不知道，就说文章质量不行，唉，好郁闷，该杂志很多年前有过我这个文章的病的报道，之后就没有了，可能不对期刊口味，再一个，可能文章质量各方面都较差吧，还想有点审稿意见，可惜都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a59109196, createdName=zyzyyan, createdTime=Mon Feb 09 11:04:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505252, encodeId=abcc5052527a, content=该杂志很少发表病例报道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Aug 12 09:46:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492288, encodeId=74ed492288d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2015-02-09 zyzyyan

审稿速度:1.0 | 投稿命中率:25.0
经验分享：唉,我的文章投稿后被秒拒，死的原因都不知道，就说文章质量不行，唉，好郁闷，该杂志很多年前有过我这个文章的病的报道，之后就没有了，可能不对期刊口味，再一个，可能文章质量各方面都较差吧，还想有点审稿意见，可惜都没有。

479 0

[GetPortalCommentsPageByObjectIdResponse(id=1087365, encodeId=db85108e365a7, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087366, encodeId=1268108e3667c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578533, encodeId=a32f5e8533ad, content=先查询下期刊文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571836, encodeId=11325e183622, content=三天秒拒，说创新性不够，有类似文章发表过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565818, encodeId=b67656581874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：这个杂志可能是BMJ的子刊，首先编辑审稿10天左右，然后外审2月，基本都是压着deadline，大修回去之后又审了1.5月，小修又是半个月，到正式online半年了，审稿严谨，而且太慢了。好文章不建议投这个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d892158901, createdName=jilei_lin_40832754, createdTime=Mon Jan 21 00:00:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832770, encodeId=dec6832e7038, content=adc本身是个临床性和社会性强的期刊，背后学会很强。儿科排名第13。审稿挺快的，如果不合适，会立刻告诉作者，不耽误改投。审稿人给的意见很中肯。 好像这个刊近年来在加强与中国的合作，投的人和中的人都不少。 其实这个刊和它的两本特刊fetal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Wed Jul 13 17:19:03 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517168, encodeId=fffa51e1682c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：欧洲儿科学会官刊，发表比较快，一审25天，接收2周后上线，审稿较严格，但只要写的认真就不算难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Fri Nov 27 14:41:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509696, encodeId=13f05096967b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：唉,我的文章投稿后被秒拒，死的原因都不知道，就说文章质量不行，唉，好郁闷，该杂志很多年前有过我这个文章的病的报道，之后就没有了，可能不对期刊口味，再一个，可能文章质量各方面都较差吧，还想有点审稿意见，可惜都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a59109196, createdName=zyzyyan, createdTime=Mon Feb 09 11:04:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505252, encodeId=abcc5052527a, content=该杂志很少发表病例报道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Aug 12 09:46:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492288, encodeId=74ed492288d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2014-08-12 jincq2008

该杂志很少发表病例报道。

441 0

[GetPortalCommentsPageByObjectIdResponse(id=1087365, encodeId=db85108e365a7, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087366, encodeId=1268108e3667c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578533, encodeId=a32f5e8533ad, content=先查询下期刊文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571836, encodeId=11325e183622, content=三天秒拒，说创新性不够，有类似文章发表过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/16/eefd0d05a09aedf198725d86975996fb.jpg, createdBy=81102357005, createdName=a pediatrics surgeon, createdTime=Mon Jun 03 00:00:00 CST 2019, time=2019-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565818, encodeId=b67656581874, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：这个杂志可能是BMJ的子刊，首先编辑审稿10天左右，然后外审2月，基本都是压着deadline，大修回去之后又审了1.5月，小修又是半个月，到正式online半年了，审稿严谨，而且太慢了。好文章不建议投这个。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d892158901, createdName=jilei_lin_40832754, createdTime=Mon Jan 21 00:00:00 CST 2019, time=2019-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832770, encodeId=dec6832e7038, content=adc本身是个临床性和社会性强的期刊，背后学会很强。儿科排名第13。审稿挺快的，如果不合适，会立刻告诉作者，不耽误改投。审稿人给的意见很中肯。 好像这个刊近年来在加强与中国的合作，投的人和中的人都不少。 其实这个刊和它的两本特刊fetal , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Wed Jul 13 17:19:03 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517168, encodeId=fffa51e1682c, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：欧洲儿科学会官刊，发表比较快，一审25天，接收2周后上线，审稿较严格，但只要写的认真就不算难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=487, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Fri Nov 27 14:41:00 CST 2015, time=2015-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509696, encodeId=13f05096967b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：唉,我的文章投稿后被秒拒，死的原因都不知道，就说文章质量不行，唉，好郁闷，该杂志很多年前有过我这个文章的病的报道，之后就没有了，可能不对期刊口味，再一个，可能文章质量各方面都较差吧，还想有点审稿意见，可惜都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a59109196, createdName=zyzyyan, createdTime=Mon Feb 09 11:04:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505252, encodeId=abcc5052527a, content=该杂志很少发表病例报道。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=441, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Aug 12 09:46:00 CST 2014, time=2014-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492288, encodeId=74ed492288d8, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=550, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]

2012-11-28 qupeter

明年能不能冲到3分？大家谈谈

550 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务